These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34244578)

  • 1. Effective silencing of miR-126 after ischemic stroke by means of intravenous α-tocopherol-conjugated heteroduplex oligonucleotide in mice.
    Suzuki M; Ishibashi S; Iwasawa E; Oguma T; Saito Y; Li F; Otsu S; Ichinose K; Yoshioka K; Nagata T; Yokota T
    Sci Rep; 2021 Jul; 11(1):14237. PubMed ID: 34244578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly efficient silencing of microRNA by heteroduplex oligonucleotides.
    Yoshioka K; Kunieda T; Asami Y; Guo H; Miyata H; Yoshida-Tanaka K; Sujino Y; Piao W; Kuwahara H; Nishina K; Hara RI; Nagata T; Wada T; Obika S; Yokota T
    Nucleic Acids Res; 2019 Aug; 47(14):7321-7332. PubMed ID: 31214713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential delivery of lipid-ligand conjugated DNA/RNA heteroduplex oligonucleotide to ischemic brain in hyperacute stage.
    Li F; Ichinose K; Ishibashi S; Yamamoto S; Iwasawa E; Suzuki M; Yoshida-Tanaka K; Yoshioka K; Nagata T; Hirabayashi H; Mogushi K; Yokota T
    Mol Ther; 2023 Apr; 31(4):1106-1122. PubMed ID: 36694463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing.
    Nishina K; Piao W; Yoshida-Tanaka K; Sujino Y; Nishina T; Yamamoto T; Nitta K; Yoshioka K; Kuwahara H; Yasuhara H; Baba T; Ono F; Miyata K; Miyake K; Seth PP; Low A; Yoshida M; Bennett CF; Kataoka K; Mizusawa H; Obika S; Yokota T
    Nat Commun; 2015 Aug; 6():7969. PubMed ID: 26258894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of miR-181b in mouse brain following ischemic stroke induces neuroprotection against ischemic injury through targeting heat shock protein A5 and ubiquitin carboxyl-terminal hydrolase isozyme L1.
    Peng Z; Li J; Li Y; Yang X; Feng S; Han S; Li J
    J Neurosci Res; 2013 Oct; 91(10):1349-62. PubMed ID: 23900885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short DNA/RNA heteroduplex oligonucleotide interacting proteins are key regulators of target gene silencing.
    Asada K; Sakaue F; Nagata T; Zhang JC; Yoshida-Tanaka K; Abe A; Nawa M; Nishina K; Yokota T
    Nucleic Acids Res; 2021 May; 49(9):4864-4876. PubMed ID: 33928345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of interaction between antimiR and microRNA versus HDO-antimiR and microRNA by molecular dynamics simulation.
    Nishina K; Yoshioka K; Yokota T; Hara RI
    Nucleosides Nucleotides Nucleic Acids; 2024 Jan; ():1-16. PubMed ID: 38205778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of blood-brain barrier function by a heteroduplex oligonucleotide in vivo.
    Kuwahara H; Song J; Shimoura T; Yoshida-Tanaka K; Mizuno T; Mochizuki T; Zeniya S; Li F; Nishina K; Nagata T; Ito S; Kusuhara H; Yokota T
    Sci Rep; 2018 Mar; 8(1):4377. PubMed ID: 29531265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-381-3p Confers Protection Against Ischemic Stroke Through Promoting Angiogenesis and Inhibiting Inflammation by Suppressing Cebpb and Map3k8.
    Li J; Lv H; Che Y
    Cell Mol Neurobiol; 2020 Nov; 40(8):1307-1319. PubMed ID: 32297103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma.
    Kunz M; Brandl M; Bhattacharya A; Nobereit-Siegel L; Ewe A; Weirauch U; Hering D; Reinert A; Kalwa H; Guzman J; Weigelt K; Wach S; Taubert H; Aigner A
    J Nanobiotechnology; 2020 Nov; 18(1):173. PubMed ID: 33228711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LNA-mediated microRNA silencing in non-human primates.
    Elmén J; Lindow M; Schütz S; Lawrence M; Petri A; Obad S; Lindholm M; Hedtjärn M; Hansen HF; Berger U; Gullans S; Kearney P; Sarnow P; Straarup EM; Kauppinen S
    Nature; 2008 Apr; 452(7189):896-9. PubMed ID: 18368051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseases.
    Ooi JYY; Bernardo BC; Singla S; Patterson NL; Lin RCY; McMullen JR
    RNA Biol; 2017 May; 14(5):500-513. PubMed ID: 27124358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA-RNA Heteroduplex Oligonucleotide for Highly Efficient Gene Silencing.
    Hara RI; Yoshioka K; Yokota T
    Methods Mol Biol; 2020; 2176():113-119. PubMed ID: 32865786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function.
    Bernardo BC; Gao XM; Winbanks CE; Boey EJ; Tham YK; Kiriazis H; Gregorevic P; Obad S; Kauppinen S; Du XJ; Lin RC; McMullen JR
    Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17615-20. PubMed ID: 23047694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracerebral overexpression of miR-669c is protective in mouse ischemic stroke model by targeting MyD88 and inducing alternative microglial/macrophage activation.
    Kolosowska N; Gotkiewicz M; Dhungana H; Giudice L; Giugno R; Box D; Huuskonen MT; Korhonen P; Scoyni F; Kanninen KM; Ylä-Herttuala S; Turunen TA; Turunen MP; Koistinaho J; Malm T
    J Neuroinflammation; 2020 Jun; 17(1):194. PubMed ID: 32560730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-137 prevents inflammatory response, oxidative stress, neuronal injury and cognitive impairment via blockade of
    Tian R; Wu B; Fu C; Guo K
    Aging (Albany NY); 2020 Jun; 12(11):10873-10895. PubMed ID: 32496209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-specific anti-RAGE exosomes for nose-to-brain delivery of anti-miR-181a oligonucleotide in an ischemic stroke model.
    Kim M; Lee Y; Lee M
    Nanoscale; 2021 Sep; 13(33):14166-14178. PubMed ID: 34477698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncovering the Potential Differentially Expressed miRNAs and mRNAs in Ischemic Stroke Based on Integrated Analysis in the Gene Expression Omnibus Database.
    Zhu X; Liu X; Liu Y; Chang W; Song Y; Zhu S
    Eur Neurol; 2020; 83(4):404-414. PubMed ID: 32906114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac repair through miR-125b-mediated prevention of cell death in myocardial infarction.
    Zhu LP; Tian T; Wang JY; He JN; Chen T; Pan M; Xu L; Zhang HX; Qiu XT; Li CC; Wang KK; Shen H; Zhang GG; Bai YP
    Theranostics; 2018; 8(22):6163-6177. PubMed ID: 30613290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic antimiR-337-3p delivery inhibits cerebral ischemia-mediated injury.
    Wang X; Suofu Y; Akpinar B; Baranov SV; Kim J; Carlisle DL; Zhang Y; Friedlander RM
    Neurobiol Dis; 2017 Sep; 105():156-163. PubMed ID: 28461247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.